Medical Pot Firm Developed A Drug NFL Players’ Protection

We’ve taken the preclinical approach so far to date on our first indication which is hepatic encephylopathy, which is a brain-liver disorder, where you do have neuronal degradation and degeneration, oxidative stress, Dean Petkanas, CEO of KannaLife Sciences told Foxiness.com. So we felt that we could look at that in parallel... more →
Posted in: News